Biotherapeutics Drug Development
This course is a part of
During this course you will, understand and address potential major challenges for biotherapeutics related to pharmaceutical formulation design, development, processing, efficacy, and safety.
This course provides an in-depth overview of the challenges and complexities involved in the development of biotherapeutics, focusing on pharmaceutical formulation, technological processing, and regulatory aspects. It addresses the key issues surrounding the development of biologically active macromolecules such as peptides, antibodies, and oligonucleotides, as well as other biological materials like living organisms and stem cells.
The course covers various stages of drug development, from discovery through to assessment, highlighting topics such as molecular engineering, drug design, efficacy and safety testing, and regulatory considerations. Case studies and expert-led discussions will be used to explore the latest advances and innovative approaches in biotherapeutic development.
Special attention is given to the need for specialised formulation and delivery strategies to overcome the challenges posed by the structural complexity and instability of these drugs. Participants will gain a comprehensive understanding of the evolving landscape of biotherapeutics and their potential for creating new, improved treatments.
For more details about the course, please refer to the course curriculum.
View all courses on:
I got a great overview of the topic and many great talks!
Course directors on »Biotherapeutics Drug Development«
Course details for »Biotherapeutics Drug Development«
Dates and Examination
Course dates
Course dates will be announced
Examination
Please find the exam dates in the exam plan.
Learning outcomes
On completion of the course, you will be able to:
-
understand and address potential major challenges for biotherapeutics related to pharmaceutical formulation design, development, processing, efficacy, and safety
-
identify key challenges and suggest solutions for addressing critical issues in the development process for biotherapeutics
-
elaborate on novel interdisciplinary approaches to improve current practice in the development of biotherapeutics
-
communicate field-specific issues and solutions regarding development of biotherapeutics to other specialists in multi-disciplinary project teams.
Admission criteria
You must meet the following criteria to be admitted to this course:
- Hold a relevant bachelor degree or equivalent.
- Have a minimum 2 years of relevant job experience in drug development.
- Be proficient in English.
Find detailed information in the admission criteria on Master of Industrial Drug Development.
Priority is given to enrolled students
This course is offered as an elective course in the Master of Industrial Drug Development programme. Priority is given to students already enrolled. Once the enrolled students have been admitted to the course, the remaining seats are distributed on a first-come, first-served basis.
Tuition fees
EU/EEA citizens
14,450 DKK
Non-EU/EEA citizens
16,580 DKK
The fee includes lunch and coffee.
More information
All course information is available in the course curriculum:Faculty of Health and Medical Sciences
Department of Pharmacy and Department of Drug Design and Pharmacology
Universitetsparken 2
DK-2100 Copenhagen
